International Stem Cell Corp (ISCO)
0.097
-0.01
(-11.01%)
USD |
OTCM |
May 03, 16:00
International Stem Cell Debt to Equity Ratio: -0.8257 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | -0.8257 |
September 30, 2023 | -0.8873 |
June 30, 2023 | -0.8814 |
March 31, 2023 | -0.7551 |
December 31, 2022 | -0.7356 |
September 30, 2022 | -0.7074 |
June 30, 2022 | -0.7374 |
March 31, 2022 | -0.7157 |
December 31, 2021 | -0.6415 |
September 30, 2021 | -0.6683 |
June 30, 2021 | -0.7791 |
March 31, 2021 | -0.8484 |
December 31, 2020 | -0.7231 |
September 30, 2020 | -0.8008 |
June 30, 2020 | -0.8533 |
March 31, 2020 | -0.8424 |
December 31, 2019 | -0.8206 |
September 30, 2019 | -2.734 |
June 30, 2019 | -1.534 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.8061 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 1.267 |
March 31, 2017 | 2.046 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 1.963 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-2.734
Minimum
Sep 2019
-0.6415
Maximum
Dec 2021
-0.9206
Average
-0.8008
Median
Sep 2020
Debt to Equity Ratio Benchmarks
AIM ImmunoTech Inc | 0.00 |
Perspective Therapeutics Inc | 0.0229 |
Protalix BioTherapeutics Inc | 0.6033 |
Electromed Inc | 0.00 |
Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 5.39M |
Total Liabilities (Quarterly) | 9.577M |
Shareholders Equity (Quarterly) | -4.187M |
Current Ratio | 0.7287 |
Net Debt Paydown Yield | -6.69% |